|
Brazil Looks to Expedite Clinical Trial Approvals With Fast-Track Regulation
Regulations on how clinical trial protocols are approved in Brazil may soon be amended to allow for swifter approvals if the protocols have already been approved by a country whose regulatory framework is recognized by Brazil, such as the U.S. Food and Drug Administration or European Medicines Agency.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives